UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of miRNA in inflammation and autoimmunity

Autoimmunity reviews, 2013-10, Vol.12 (12), p.1160-1165

2013

Volltextzugriff (PDF)

Th17 cells in inflammation and autoimmunity

Autoimmunity reviews, 2014-12, Vol.13 (12), p.1174-1181

2014

Volltextzugriff (PDF)

Interferon Genes Are Influenced by 17β-Estradiol in SLE

Frontiers in immunology, 2021-10, Vol.12, p.725325-725325

2021

Volltextzugriff (PDF)

Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus

Frontiers in immunology, 2022-04, Vol.13, p.848149-848149

2022

Volltextzugriff (PDF)

Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8 + and CD4 + Regulatory T Cells in Lupus

Frontiers in immunology, 2021-11, Vol.12, p.718359-718359

2021

Volltextzugriff (PDF)

Effects of Peptide-Induced Immune Tolerance on Murine Lupus

Frontiers in immunology, 2021-05, Vol.12, p.662901-662901

2021

Volltextzugriff (PDF)

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria

Journal of rheumatology, 2019-07, Vol.46 (7), p.721-726

2019

Volltextzugriff (PDF)

Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus

Proceedings of the National Academy of Sciences - PNAS, 2010-09, Vol.107 (36), p.15838-15843

2010

Volltextzugriff (PDF)

Laquinimod Delays and Suppresses Nephritis in Lupus‐Prone Mice and Affects Both Myeloid and Lymphoid Immune Cells

Arthritis & rheumatology (Hoboken, N.J.), 2014-03, Vol.66 (3), p.674-685

2014

Volltextzugriff (PDF)

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia

Journal of autoimmunity, 2007-03, Vol.28 (2), p.69-75

2007

Volltextzugriff (PDF)

The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial

Annals of internal medicine, 2005-06, Vol.142 (12 Pt 1), p.953

2005

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

The Lancet (British edition), 2018-10, Vol.392 (10155), p.1330-1339

2018

Volltextzugriff (PDF)

Accelerated atherosclerosis in patients with SLE--mechanisms and management

Nature reviews. Rheumatology, 2012-04, Vol.8 (4), p.214-223

2012

Volltextzugriff (PDF)

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

Arthritis research & therapy, 2008-01, Vol.10 (4), p.213-213

2008

Volltextzugriff (PDF)

A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus

ACR open rheumatology, 2021-04, Vol.3 (4), p.209-220

2021

Volltextzugriff (PDF)

A Stop Codon Polymorphism of Toll-Like Receptor 5 Is Associated with Resistance to Systemic Lupus Erythematosus

Proceedings of the National Academy of Sciences - PNAS, 2005-07, Vol.102 (30), p.10593-10597

2005

Volltextzugriff (PDF)

Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2020-05, Vol.72 (5), p.761-768

2020

Volltextzugriff (PDF)

Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2022-07, Vol.81 (11), p.1556-1563

2022

Volltextzugriff (PDF)

Pregnancy in Women With Systemic Lupus Erythematosus: Messages for the Clinician

Annals of internal medicine, 2015-08, Vol.163 (3), p.232-233

Hahn, Bevra H

2015

Volltextzugriff (PDF)

A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases

Nature genetics, 2017-03, Vol.49 (3), p.433-437

2017

Volltextzugriff (PDF)

Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease

The Journal of immunology (1950), 2013-06, Vol.190 (11), p.5402-5410

2013

Volltextzugriff (PDF)

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Arthritis care & research (2010), 2012-06, Vol.64 (6), p.797-808

2012

Volltextzugriff (PDF)

Cutting Edge: Regulatory T Cells Directly Suppress B Cells in Systemic Lupus Erythematosus

The Journal of immunology (1950), 2009-08, Vol.183 (3), p.1518-1522

2009

Volltextzugriff (PDF)

Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study

Journal of rheumatology, 2022-04, Vol.49 (4), p.380-387

2022

Volltextzugriff (PDF)

Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2021-03, Vol.73 (3), p.472-477

2021

Volltextzugriff (PDF)

1 – 25 von 264

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(218)

Publikationsform

Artikel
(248)
Buchkapitel
(13)
Bücher
(2)
Berichte
(1)

Sprache

Englisch
(264)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Life Sciences & Biomedicine
(146)
Humans
(126)
Rheumatology
(89)
Female
(87)
Animals
(65)
Lupus Erythematosus, Systemic - Immunology
(57)
Biological And Medical Sciences
(52)
Male
(52)
Mice
(51)
Systemic Lupus Erythematosus
(51)
Medical Sciences
(48)
Immunology
(45)
Adult
(40)
Lupus
(40)
Middle Aged
(34)
Lupus Erythematosus, Systemic - Genetics
(30)
Autoimmunity
(22)
Mice, Inbred Nzb
(21)
Autoimmune Diseases
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of miRNA in inflammation and autoimmunity

Th17 cells in inflammation and autoimmunity

Interferon Genes Are Influenced by 17β-Estradiol in SLE

Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus

Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8 + and CD4 + Regulatory T Cells in Lupus

Effects of Peptide-Induced Immune Tolerance on Murine Lupus

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria

Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus

Laquinimod Delays and Suppresses Nephritis in Lupus‐Prone Mice and Affects Both Myeloid and Lymphoid Immune Cells

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia

The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Accelerated atherosclerosis in patients with SLE--mechanisms and management

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus

A Stop Codon Polymorphism of Toll-Like Receptor 5 Is Associated with Resistance to Systemic Lupus Erythematosus

Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus

Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus

Pregnancy in Women With Systemic Lupus Erythematosus: Messages for the Clinician

A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases

Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Cutting Edge: Regulatory T Cells Directly Suppress B Cells in Systemic Lupus Erythematosus

Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study

Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus

Suchergebnisse filtern